发明名称 |
COMBINATION THERAPY USING DUAL INHIBITOR OF C-MET AND EGFR AND IGF-1R INHIBITOR |
摘要 |
A method of preventing and/or treating a cancer, the method including co-administering a dual inhibitor of c-Met and EGFR (hereinafter, ‘c-Met/EGFR dual inhibitor’) and an IGF-1R inhibitor to a subject in need thereof and a use of IGF-1R as a marker for resistance to a c-Met/EGFR dual inhibitor |
申请公布号 |
US2016144028(A1) |
申请公布日期 |
2016.05.26 |
申请号 |
US201514949303 |
申请日期 |
2015.11.23 |
申请人 |
Samsung Electronics Co., Ltd. |
发明人 |
Lee Jimin;Kim Bo Gyou;Oh Seungja;Kim Kyung Ah;Lin Powei;Lee Saet Byoul |
分类号 |
A61K39/395;G01N33/574;A61K31/4985 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a cancer in a subject, comprising co-administering a c-Met/EGFR dual inhibitor and an insulin-like growth factor 1 receptor (IGF-1R) inhibitor to the subject. |
地址 |
Suwon-si KR |